CTIS.eu › Cities › France › Paris
Paris
France
2,286 total trials
1,022 recruiting
Filter these 2,286 trials by phase, condition, sponsor and more.
Open in Search →
2024-516104-42-00
1
2022-02-17
hematologic malignancies ; acute myeloid leukemias
2024-515038-34-00
6
2022-02-10
Interest of adding donepezil to the non-medicinal care pathway recomme
2024-513857-55-00
4
2022-02-08
Achondroplasia
2024-511609-44-00
10
2022-02-03
Rectum cancer
2023-504166-37-00
4
2022-02-01
Advanced ovarian, tubal or peritoneal cancer.
2023-508963-58-00
4
2022-01-31
Symptomatic hypertrophic cardiomyopathy (HCM)
2024-510690-16-00
5
2022-01-31
Relapsed/refractory follicular lymphoma
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
2024-512631-77-00
4
2021-12-20
locally advanced or metastatic Gastrointestinal Stromal Tumors
2024-511001-28-00
4
2021-12-13
Neuroendocrine tumor
2024-512632-30-00
4
2021-12-02
X-linked hypohidrotic ectodermal dysplasia (XLHED)
2024-515075-36-00
6
2021-12-01
kidney transplantion -Epstein Barr virus
2023-505825-15-00
4
2021-10-29
Lupus Nephritis (LN)
2024-516728-32-00
10
2021-10-29
Indolent Systemic Mastocytosis and SSM
2024-513854-31-00
10
2021-10-27
Generalized Myasthenia Gravis
2024-517675-20-00
11
2021-09-28
Labor Induction of women with an unfavorable Cervix after 24 hours of
2024-511822-30-00
11
2021-09-22
Crohn’s disease
2024-511246-39-00
1
2021-07-27
Solid tumours with HER2 aberrations
2024-512953-26-00
5
2021-07-06
intermediate-stage hepatocellular carcinoma
2024-515344-23-00
4
2021-06-17
local advenced pancreatic adenocarcinoma
2024-517215-67-00
5
2021-06-11
Newly diagnosed Non-Frail transplant Ineligible Multiple Myeloma elder
2024-516181-11-00
4
2021-06-10
RELAPSE/REFRACTORY B-CELL LYMPHOMA.
2024-510653-10-00
5
2021-06-04
Advanced or metastatic soft tissue sarcoma (STS) in patients ≥65 years
2024-511867-27-00
5
2021-06-02
Vascular calcification and type 1 diabetes
Showing 1,153–1,176 of 2,286 trials